Brian R Slawski
Examiner (ID: 259, Phone: (571)270-3855 , Office: P/1745 )
Most Active Art Unit | 1745 |
Art Unit(s) | 1791, 1745 |
Total Applications | 835 |
Issued Applications | 640 |
Pending Applications | 49 |
Abandoned Applications | 146 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 14864919
[patent_doc_number] => 20190282701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => CONJUGATES OF HYALURONIC ACID AND ANTICANCER COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/318328
[patent_app_country] => US
[patent_app_date] => 2017-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318328
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/318328 | CONJUGATES OF HYALURONIC ACID AND ANTICANCER COMPOUNDS | Jul 24, 2017 | Abandoned |
Array
(
[id] => 14833345
[patent_doc_number] => 20190275073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => VIRUCIDAL COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/319009
[patent_app_country] => US
[patent_app_date] => 2017-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6795
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16319009
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/319009 | VIRUCIDAL COMPOUNDS AND USES THEREOF | Jul 19, 2017 | Abandoned |
Array
(
[id] => 16883831
[patent_doc_number] => 20210170026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => ANTICANCER AGENT, RADIOSENSITIZER, AND FOOD COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/317358
[patent_app_country] => US
[patent_app_date] => 2017-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6213
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16317358
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/317358 | ANTICANCER AGENT, RADIOSENSITIZER, AND FOOD COMPOSITION | Jul 9, 2017 | Abandoned |
Array
(
[id] => 16321313
[patent_doc_number] => 10781269
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-22
[patent_title] => Nacre-mimetic environmentally friendly composite membrane with "interpenetrating petal" structure and preparation method thereof
[patent_app_type] => utility
[patent_app_number] => 16/315165
[patent_app_country] => US
[patent_app_date] => 2017-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2829
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315165
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315165 | Nacre-mimetic environmentally friendly composite membrane with "interpenetrating petal" structure and preparation method thereof | Jun 27, 2017 | Issued |
Array
(
[id] => 16572926
[patent_doc_number] => 10894839
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-19
[patent_title] => Process for making Sugammadex
[patent_app_type] => utility
[patent_app_number] => 16/311495
[patent_app_country] => US
[patent_app_date] => 2017-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2342
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311495
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/311495 | Process for making Sugammadex | Jun 21, 2017 | Issued |
Array
(
[id] => 16861700
[patent_doc_number] => 11020422
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-01
[patent_title] => Cyclodextrin for the treatment of lysosomal storage diseases
[patent_app_type] => utility
[patent_app_number] => 15/620753
[patent_app_country] => US
[patent_app_date] => 2017-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 25
[patent_no_of_words] => 13854
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15620753
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/620753 | Cyclodextrin for the treatment of lysosomal storage diseases | Jun 11, 2017 | Issued |
Array
(
[id] => 17911320
[patent_doc_number] => 20220313715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => PHARMACEUTICAL COMPOSITION, FOR PREVENTING OR TREATING HEPATIC FIBROSIS, COMPRISING 8-OHDG
[patent_app_type] => utility
[patent_app_number] => 16/306183
[patent_app_country] => US
[patent_app_date] => 2017-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5951
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16306183
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/306183 | PHARMACEUTICAL COMPOSITION, FOR PREVENTING OR TREATING HEPATIC FIBROSIS, COMPRISING 8-OHDG | May 28, 2017 | Pending |
Array
(
[id] => 16359349
[patent_doc_number] => 20200316100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => HALOALKYL FUCOSE-CONTAINING SELECTIN ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/303852
[patent_app_country] => US
[patent_app_date] => 2017-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31800
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16303852
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/303852 | HALOALKYL FUCOSE-CONTAINING SELECTIN ANTAGONISTS | May 21, 2017 | Abandoned |
Array
(
[id] => 13091123
[patent_doc_number] => 10064886
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-04
[patent_title] => Composition based on xyloglucan and proteins for the treatment of intestinal disorders
[patent_app_type] => utility
[patent_app_number] => 15/597664
[patent_app_country] => US
[patent_app_date] => 2017-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1700
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15597664
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/597664 | Composition based on xyloglucan and proteins for the treatment of intestinal disorders | May 16, 2017 | Issued |
Array
(
[id] => 11820645
[patent_doc_number] => 20170209583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'COMPOSITIONS AND METHODS FOR DELIVERING AN AGENT TO A WOUND'
[patent_app_type] => utility
[patent_app_number] => 15/483686
[patent_app_country] => US
[patent_app_date] => 2017-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 23278
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15483686
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/483686 | Compositions and methods for delivering an agent to a wound | Apr 9, 2017 | Issued |
Array
(
[id] => 15405259
[patent_doc_number] => 20200022951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => MULTIVITAMIN COMPOSITION FOR IMPROVING VERBAL FLUENCY, DECREASING PERFORMANCE ANXIETY SYMPTOMS AND METHOD FOR PREPARING SAME
[patent_app_type] => utility
[patent_app_number] => 16/497489
[patent_app_country] => US
[patent_app_date] => 2017-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7683
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16497489
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/497489 | MULTIVITAMIN COMPOSITION FOR IMPROVING VERBAL FLUENCY, DECREASING PERFORMANCE ANXIETY SYMPTOMS AND METHOD FOR PREPARING SAME | Mar 29, 2017 | Abandoned |
Array
(
[id] => 11864747
[patent_doc_number] => 20170232033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'METHODS AND MATERIALS RELATED TO NUTRITIONAL SUPPLEMENT COMPOSITIONS CONTAINING A POTATO POLYSACCHARIDE PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 15/472559
[patent_app_country] => US
[patent_app_date] => 2017-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 9653
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15472559
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/472559 | METHODS AND MATERIALS RELATED TO NUTRITIONAL SUPPLEMENT COMPOSITIONS CONTAINING A POTATO POLYSACCHARIDE PREPARATION | Mar 28, 2017 | Abandoned |
Array
(
[id] => 15321021
[patent_doc_number] => 20200000840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => USE OF CYCLODEXTRINS TO REDUCE ENDOCYTOSIS IN MALIGNANT AND NEURODEGENERATIVE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/086946
[patent_app_country] => US
[patent_app_date] => 2017-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27443
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16086946
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/086946 | USE OF CYCLODEXTRINS TO REDUCE ENDOCYTOSIS IN MALIGNANT AND NEURODEGENERATIVE DISORDERS | Mar 19, 2017 | Abandoned |
Array
(
[id] => 17859786
[patent_doc_number] => 11440931
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-13
[patent_title] => Crocins compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/097166
[patent_app_country] => US
[patent_app_date] => 2017-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5279
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097166
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097166 | Crocins compounds and uses thereof | Mar 15, 2017 | Issued |
Array
(
[id] => 14519075
[patent_doc_number] => 10336784
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => Methods for modular synthesis of N-glycans and arrays thereof
[patent_app_type] => utility
[patent_app_number] => 15/453836
[patent_app_country] => US
[patent_app_date] => 2017-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 237
[patent_figures_cnt] => 248
[patent_no_of_words] => 67346
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 240
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15453836
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/453836 | Methods for modular synthesis of N-glycans and arrays thereof | Mar 7, 2017 | Issued |
Array
(
[id] => 14132315
[patent_doc_number] => 20190100547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => METHOD FOR PREPARING 2'-O-FUCOSYLLACTOSE
[patent_app_type] => utility
[patent_app_number] => 16/082581
[patent_app_country] => US
[patent_app_date] => 2017-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16082581
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/082581 | METHOD FOR PREPARING 2'-O-FUCOSYLLACTOSE | Mar 7, 2017 | Abandoned |
Array
(
[id] => 16913879
[patent_doc_number] => 20210186971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => BRAIN HEALTH FOOD OR BRAIN HEALTH BEVERAGE, AND METHOD FOR ADMINISTERING SAME
[patent_app_type] => utility
[patent_app_number] => 16/080983
[patent_app_country] => US
[patent_app_date] => 2017-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5670
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16080983
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/080983 | BRAIN HEALTH FOOD OR BRAIN HEALTH BEVERAGE, AND METHOD FOR ADMINISTERING SAME | Feb 26, 2017 | Abandoned |
Array
(
[id] => 11864731
[patent_doc_number] => 20170232017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/443698
[patent_app_country] => US
[patent_app_date] => 2017-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14531
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15443698
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/443698 | TREATMENT OF CANCER | Feb 26, 2017 | Abandoned |
Array
(
[id] => 12246296
[patent_doc_number] => 09919060
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-20
[patent_title] => 'Treatment or prophylaxis of proliferative conditions'
[patent_app_type] => utility
[patent_app_number] => 15/425758
[patent_app_country] => US
[patent_app_date] => 2017-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 39356
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15425758
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/425758 | Treatment or prophylaxis of proliferative conditions | Feb 5, 2017 | Issued |
Array
(
[id] => 16635267
[patent_doc_number] => 10913762
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-09
[patent_title] => Process for the preparation of D-glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl] oxy]phenyl] methyl] phenyl]-, (1S) and its crystalline forms thereof
[patent_app_type] => utility
[patent_app_number] => 16/073714
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 10224
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073714
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073714 | Process for the preparation of D-glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl] oxy]phenyl] methyl] phenyl]-, (1S) and its crystalline forms thereof | Jan 26, 2017 | Issued |